Octahydro fused azadecalin glucocorticoid receptor modulators
US10323034B2 · kind B2 · utility
17Cited by
12References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2018 |
| Grant date | Jun 18, 2019 |
| Priority date | — |
| Expiry date | Oct 16, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.